296 related articles for article (PubMed ID: 32062567)
21. Deep gray matter volume loss drives disability worsening in multiple sclerosis.
Eshaghi A; Prados F; Brownlee WJ; Altmann DR; Tur C; Cardoso MJ; De Angelis F; van de Pavert SH; Cawley N; De Stefano N; Stromillo ML; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Vrenken H; Leurs CE; Killestein J; Pirpamer L; Enzinger C; Ourselin S; Wheeler-Kingshott CAMG; Chard D; Thompson AJ; Alexander DC; Barkhof F; Ciccarelli O;
Ann Neurol; 2018 Feb; 83(2):210-222. PubMed ID: 29331092
[TBL] [Abstract][Full Text] [Related]
22. The impact of deep grey matter volume on cognition in multiple sclerosis.
Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G
Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200
[TBL] [Abstract][Full Text] [Related]
23. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
24. Multimodal quantitative MRI assessment of cortical damage in relapsing-remitting multiple sclerosis.
Gracien RM; Jurcoane A; Wagner M; Reitz SC; Mayer C; Volz S; Hof SM; Fleischer V; Droby A; Steinmetz H; Groppa S; Hattingen E; Deichmann R; Klein JC
J Magn Reson Imaging; 2016 Dec; 44(6):1600-1607. PubMed ID: 27153293
[TBL] [Abstract][Full Text] [Related]
25. Regional gray matter atrophy in relapsing remitting multiple sclerosis: baseline analysis of multi-center data.
Datta S; Staewen TD; Cofield SS; Cutter GR; Lublin FD; Wolinsky JS; Narayana PA; ;
Mult Scler Relat Disord; 2015 Mar; 4(2):124-36. PubMed ID: 25787188
[TBL] [Abstract][Full Text] [Related]
26. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
[TBL] [Abstract][Full Text] [Related]
27. Multimodal assessment of regional gray matter integrity in early relapsing-remitting multiple sclerosis patients with normal cognition: a voxel-based structural and perfusion approach.
Shooli H; Nemati R; Chabi N; Larvie M; Jokar N; Dadgar H; Gholamrezanezhad A; Assadi M
Br J Radiol; 2021 Nov; 94(1127):20210308. PubMed ID: 34491820
[TBL] [Abstract][Full Text] [Related]
28. Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: A two-year longitudinal study.
Uddin MN; Lebel RM; Seres P; Blevins G; Wilman AH
Mult Scler; 2016 Aug; 22(9):1133-43. PubMed ID: 26503237
[TBL] [Abstract][Full Text] [Related]
29. Voxel-Based quantitative MRI reveals spatial patterns of grey matter alteration in multiple sclerosis.
Lommers E; Guillemin C; Reuter G; Fouarge E; Delrue G; Collette F; Degueldre C; Balteau E; Maquet P; Phillips C
Hum Brain Mapp; 2021 Mar; 42(4):1003-1012. PubMed ID: 33155763
[TBL] [Abstract][Full Text] [Related]
30. Multiparameter MRI quantification of microstructural tissue alterations in multiple sclerosis.
Lommers E; Simon J; Reuter G; Delrue G; Dive D; Degueldre C; Balteau E; Phillips C; Maquet P
Neuroimage Clin; 2019; 23():101879. PubMed ID: 31176293
[TBL] [Abstract][Full Text] [Related]
31. Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study.
Bergsland N; Horakova D; Dwyer MG; Uher T; Vaneckova M; Tyblova M; Seidl Z; Krasensky J; Havrdova E; Zivadinov R
Neuroimage Clin; 2018; 17():444-451. PubMed ID: 29159057
[TBL] [Abstract][Full Text] [Related]
32. Increased total sodium concentration in gray matter better explains cognition than atrophy in MS.
Maarouf A; Audoin B; Pariollaud F; Gherib S; Rico A; Soulier E; Confort-Gouny S; Guye M; Schad L; Pelletier J; Ranjeva JP; Zaaraoui W
Neurology; 2017 Jan; 88(3):289-295. PubMed ID: 27974643
[TBL] [Abstract][Full Text] [Related]
33. Five year iron changes in relapsing-remitting multiple sclerosis deep gray matter compared to healthy controls.
Elkady AM; Cobzas D; Sun H; Seres P; Blevins G; Wilman AH
Mult Scler Relat Disord; 2019 Aug; 33():107-115. PubMed ID: 31181540
[TBL] [Abstract][Full Text] [Related]
34. Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis.
Meijboom R; York EN; Kampaite A; Harris MA; White N; Valdés Hernández MDC; Thrippleton MJ; MacDougall NJJ; Connick P; Hunt DPJ; Chandran S; Waldman AD;
PLoS One; 2023; 18(7):e0288967. PubMed ID: 37506096
[TBL] [Abstract][Full Text] [Related]
35. Clinical correlates of R1 relaxometry and magnetic susceptibility changes in multiple sclerosis: a multi-parameter quantitative MRI study of brain iron and myelin.
Pontillo G; Petracca M; Monti S; Quarantelli M; Lanzillo R; Costabile T; Carotenuto A; Tortora F; Elefante A; Morra VB; Brunetti A; Palma G; Cocozza S
Eur Radiol; 2023 Mar; 33(3):2185-2194. PubMed ID: 36241917
[TBL] [Abstract][Full Text] [Related]
36. Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study.
Hidalgo de la Cruz M; Valsasina P; Meani A; Gallo A; Gobbi C; Bisecco A; Tedeschi G; Zecca C; Rocca MA; Filippi M
Mult Scler; 2022 Mar; 28(3):406-417. PubMed ID: 34124963
[TBL] [Abstract][Full Text] [Related]
37. Fast whole-brain three-dimensional macromolecular proton fraction mapping in multiple sclerosis.
Yarnykh VL; Bowen JD; Samsonov A; Repovic P; Mayadev A; Qian P; Gangadharan B; Keogh BP; Maravilla KR; Jung Henson LK
Radiology; 2015 Jan; 274(1):210-20. PubMed ID: 25208343
[TBL] [Abstract][Full Text] [Related]
38. Estriol-mediated neuroprotection in multiple sclerosis localized by voxel-based morphometry.
MacKenzie-Graham A; Brook J; Kurth F; Itoh Y; Meyer C; Montag MJ; Wang HJ; Elashoff R; Voskuhl RR
Brain Behav; 2018 Sep; 8(9):e01086. PubMed ID: 30144306
[TBL] [Abstract][Full Text] [Related]
39. Contribution of Gray and White Matter Abnormalities to Cognitive Impairment in Multiple Sclerosis.
Zhang X; Zhang F; Huang D; Wu L; Ma L; Liu H; Zhao Y; Yu S; Shi J
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28035997
[TBL] [Abstract][Full Text] [Related]
40. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
